Medical Castration From GTx Prostate Cancer Drug
Links shared publicly online about this topic
GTx-prostate cancer drug causes medical castration http://bit.ly/9Lvm6W
reuters.com — “GTx-prostate cancer drug causes medical castration http://bit.ly/9Lvm6W” View full resource at reuters.com
Most Recently Shared on September 15, 2010 at 1:02 pm By:
GTx-prostate cancer drug causes medical castration http://bit.ly/9Lvm6W
Medical News: Drug Ups Survival in Advanced Prostate Cancer - in Oncology, Prostate Cancer from MedPage Today
medpagetoday.com — “Men with metastatic castration-resistant prostate cancer had a four-month improvement in survival when treated with the androgen biosynthesis inhibitor abiraterone (Zytiga) after progression on doceta” View full resource at medpagetoday.com
Most Recently Shared on May 25, 2011 at 9:16 pm By:
Drug Ups Survival in Advanced Prostate Cancer: Men with metastatic castration-resistant prostate cancer had a fo... http://bit.ly/k0APB6
Medical News: Drug Active in Advanced Prostate Cancer - in Oncology, Prostate Cancer from MedPage Today
medpagetoday.com — “An investigational antiandrogen showed substantial antitumor activity in men with castration-resistant prostate cancer, data from a preliminary clinical trial showed.” View full resource at medpagetoday.com
Most Recently Shared on April 18, 2010 at 8:16 pm By:
Medical News: Drug Active in Advanced Prostate Cancer - in Oncology, Prostate Cancer from MedPage Today
medpagetoday.com — “An investigational antiandrogen showed substantial antitumor activity in men with castration-resistant prostate cancer, data from a preliminary clinical trial showed.” View full resource at medpagetoday.com
Most Recently Shared on April 15, 2010 at 4:59 pm By:
Drug Active in Advanced Prostate Cancer (CME/CE, with audio) http://bit.ly/97msyj
Medical News: AUA: Drug Slows Bone Mets in Prostate Cancer - in Meeting Coverage, AUA from MedPage Today
medpagetoday.com — “WASHINGTON -- Bone metastasis slowed significantly in men with castration-resistant prostate cancer treated with denosumab (Xgeva), data from an international randomized trial showed.” View full resource at medpagetoday.com
Most Recently Shared on May 24, 2011 at 1:57 pm By:
Medical News: AUA: Drug Slows Bone Mets in Prostate Cancer - in ... http://bit.ly/k2i0G8
Medical News: AUA: Drug Slows Bone Mets in Prostate Cancer - in Meeting Coverage, AUA from MedPage Today
medpagetoday.com — “WASHINGTON -- Bone metastasis slowed significantly in men with castration-resistant prostate cancer treated with denosumab (Xgeva), data from an international randomized trial showed.” View full resource at medpagetoday.com
Most Recently Shared on May 24, 2011 at 2:17 pm By:
AUA: Drug Slows Bone Mets in Prostate Cancer: WASHINGTON -- Bone metastasis slowed significantly in men with cas... http://bit.ly/jkVzww
Medical News: ASCO: Bone Effects Fuel Optimism for Prostate Ca Drug - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Two-thirds of men with castration-resistant prostate cancer (CRPC) had clinical benefit when treated with an investigational multitargeted tyrosine kinase inhibitor, data from a randomized” View full resource at medpagetoday.com
Most Recently Shared on June 9, 2011 at 2:44 pm By:
ASCO: Bone Effects Fuel Optimism for Prostate Ca Drug: CHICAGO -- Two thirds of men with castration-resistant pr... http://bit.ly/lOURNM
Medical News: ASCO: Bone Effects Fuel Optimism for Prostate Ca Drug - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Two-thirds of men with castration-resistant prostate cancer (CRPC) had clinical benefit when treated with an investigational multitargeted tyrosine kinase inhibitor, data from a randomized” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 7:33 pm By:
Medical News: ASCO: Bone Effects Fuel Optimism for Prostate Ca Drug - http://t.co/GjoUOns from @medpagetoday #health #medicine
Medical News: FDA Okays New Drug for Advanced Prostate Ca - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved abiraterone acetate (Zytiga) for treatment of late-stage, castration-resistant prostate cancer as a combination therapy with prednisone in patients who have received” View full resource at medpagetoday.com
Most Recently Shared on April 29, 2011 at 4:55 pm By:
FDA Okays New Drug for Advanced Prostate Ca http://bit.ly/k4ZqIh
Medical News: ASCO: Bone Effects Fuel Optimism for Prostate Ca Drug - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Two-thirds of men with castration-resistant prostate cancer (CRPC) had clinical benefit when treated with an investigational multitargeted tyrosine kinase inhibitor, data from a randomized” View full resource at medpagetoday.com
Most Recently Shared on June 9, 2011 at 3:06 pm By:
ASCO: Bone Effects Fuel Optimism for Prostate Ca Drug (with video) http://bit.ly/m1iiPd
NCI Cancer Bulletin for October 19, 2010 - National Cancer Institute
cancer.gov — “NCI's biweekly online newsletter provides useful, timely information about cancer research to the cancer community.” View full resource at cancer.gov
Most Recently Shared on October 20, 2010 at 12:01 am By:
Abiraterone improves survival in metastatic prostate cancer: http://bit.ly/dCUqbB
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Prostate Cancer
You just hit the official Twitter Page of Prostate Cancer Community! We have the info you need when it come to Prostate Cancer. Dive in and get connected!
-
john clay mchugh
Gainesville, Ga urologist treated for prostate cancer has authored a book on prostate cancer. He has an informative and eclectic prostate cancer blog.
-
Prostate Cancer
You just hit the official Twitter Page of Prostate Cancer Community! We have the info you need when it come to Prostate Cancer. Dive in and get connected!
Advertisement

